The enantioselective binding of mefloquine enantiomers to P-glycoprotein determined using an immobilized P-glycoprotein liquid chromatographic stationary phase.
The enantioselective binding of mefloquine enantiomers to P-glycoprotein determined using an immobilized P-glycoprotein liquid chromatographic stationary phase.
复制标题
使用固定化 P-糖蛋白液相色谱固定相测定甲氟喹对映体与 P-糖蛋白的对映选择性结合。
DOI:
10.1023/a:1013098213770
复制
发表时间:
2001
影响因子:
3.7
通讯作者:
Wainer,IW
中科院分区:
文献类型:
--
作者:
Lu,L;Leonessa,F;Baynham,MT;Clarke,R;Gimenez,F;Pham,YT;Roux,F;Wainer,IW
Mefloquine (MQ), α-2-piperidinyl-2, 8-bis (trifluoromethyl)-4-quinolinemethanol (Fig. 1), is an antimalarial agent widely used to treat chloroquine-resistant malaria (1). The agent is administered as a racemic mixture of erythroisomers,(+)-[11R, 2S]-MQ {(+)-MQ} and (−)-[11S, 2R]-MQ {(−)-MQ}. In humans, there is an enantioselective distribution of MQ with higher plasma and brain concentrations of (−)-MQ (2, 3).MQ has also been shown to inhibit the activity of the drug efflux transporter P-glycoprotein (Pgp)(4–7). Shao et al. demonstrated that MQ increased the intracellular accumulation of the Pgp substrate daunomycin in the P388/ADR leukemia cell line (4). In addition, when MQ was used concomitantly with the Pgp-substrate vinblastine (VBL), the two agents interacted with each other synergistically in a noncompetitive manner.